ELEV
Price
$0.31
Change
+$0.01 (+3.33%)
Updated
Jun 5 closing price
Capitalization
17.84M
61 days until earnings call
TBPH
Price
$11.25
Change
+$0.48 (+4.46%)
Updated
Jun 6, 11:22 AM (EDT)
Capitalization
539.01M
66 days until earnings call
Interact to see
Advertisement

ELEV vs TBPH

Header iconELEV vs TBPH Comparison
Open Charts ELEV vs TBPHBanner chart's image
Elevation Oncology
Price$0.31
Change+$0.01 (+3.33%)
Volume$292.66K
Capitalization17.84M
Theravance Biopharma
Price$11.25
Change+$0.48 (+4.46%)
Volume$200
Capitalization539.01M
ELEV vs TBPH Comparison Chart
Loading...
ELEV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ELEV vs. TBPH commentary
Jun 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ELEV is a StrongBuy and TBPH is a StrongBuy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 06, 2025
Stock price -- (ELEV: $0.30 vs. TBPH: $10.78)
Brand notoriety: ELEV and TBPH are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ELEV: 31% vs. TBPH: 88%
Market capitalization -- ELEV: $17.84M vs. TBPH: $539.01M
ELEV [@Biotechnology] is valued at $17.84M. TBPH’s [@Biotechnology] market capitalization is $539.01M. The market cap for tickers in the [@Biotechnology] industry ranges from $323.27B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ELEV’s FA Score shows that 1 FA rating(s) are green whileTBPH’s FA Score has 0 green FA rating(s).

  • ELEV’s FA Score: 1 green, 4 red.
  • TBPH’s FA Score: 0 green, 5 red.
According to our system of comparison, TBPH is a better buy in the long-term than ELEV.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ELEV’s TA Score shows that 2 TA indicator(s) are bullish while TBPH’s TA Score has 6 bullish TA indicator(s).

  • ELEV’s TA Score: 2 bullish, 5 bearish.
  • TBPH’s TA Score: 6 bullish, 4 bearish.
According to our system of comparison, TBPH is a better buy in the short-term than ELEV.

Price Growth

ELEV (@Biotechnology) experienced а -1.60% price change this week, while TBPH (@Biotechnology) price change was +15.91% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +11.36%. For the same industry, the average monthly price growth was +17.10%, and the average quarterly price growth was +3.20%.

Reported Earning Dates

ELEV is expected to report earnings on Aug 06, 2025.

TBPH is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+11.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
TBPH($539M) has a higher market cap than ELEV($17.8M). TBPH YTD gains are higher at: 14.559 vs. ELEV (-46.463). TBPH (-38.45M) and ELEV (-40.42M) have comparable annual earnings (EBITDA) . ELEV has more cash in the bank: 93.2M vs. TBPH (88.4M). ELEV has less debt than TBPH: ELEV (31.1M) vs TBPH (49.8M). TBPH has higher revenues than ELEV: TBPH (64.4M) vs ELEV (0).
ELEVTBPHELEV / TBPH
Capitalization17.8M539M3%
EBITDA-40.42M-38.45M105%
Gain YTD-46.46314.559-319%
P/E RatioN/AN/A-
Revenue064.4M-
Total Cash93.2M88.4M105%
Total Debt31.1M49.8M62%
FUNDAMENTALS RATINGS
TBPH: Fundamental Ratings
TBPH
OUTLOOK RATING
1..100
58
VALUATION
overvalued / fair valued / undervalued
1..100
41
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
44
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ELEVTBPH
RSI
ODDS (%)
N/A
Bearish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
82%
Momentum
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
76%
MACD
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
77%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
88%
Bullish Trend 1 day ago
75%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
77%
Advances
ODDS (%)
N/A
Bullish Trend 18 days ago
72%
Declines
ODDS (%)
Bearish Trend 1 day ago
89%
Bearish Trend 1 day ago
73%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
85%
Bearish Trend 1 day ago
86%
Aroon
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
View a ticker or compare two or three
Interact to see
Advertisement
ELEV
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
TBPH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CPAY331.064.18
+1.28%
Corpay
USCB16.260.12
+0.74%
USCB Financial Holdings
MSEX56.240.10
+0.18%
Middlesex Water Company
MAN40.15-0.51
-1.25%
ManpowerGroup
SABS1.83-0.03
-1.74%
SAB Biotherapeutics

ELEV and

Correlation & Price change

A.I.dvisor indicates that over the last year, ELEV has been loosely correlated with TBPH. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ELEV jumps, then TBPH could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ELEV
1D Price
Change %
ELEV100%
-0.99%
TBPH - ELEV
39%
Loosely correlated
-2.09%
BOLT - ELEV
31%
Poorly correlated
-7.97%
ADAP - ELEV
30%
Poorly correlated
+0.25%
AUTL - ELEV
29%
Poorly correlated
+8.13%
AKBA - ELEV
29%
Poorly correlated
+1.65%
More

TBPH and

Correlation & Price change

A.I.dvisor indicates that over the last year, TBPH has been loosely correlated with KYMR. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if TBPH jumps, then KYMR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To TBPH
1D Price
Change %
TBPH100%
-2.09%
KYMR - TBPH
40%
Loosely correlated
+7.68%
ELEV - TBPH
39%
Loosely correlated
-0.99%
BPMC - TBPH
38%
Loosely correlated
-0.14%
VERA - TBPH
37%
Loosely correlated
-4.27%
AXON - TBPH
34%
Loosely correlated
+1.08%
More